生物学标志物对肾脏替代治疗的预测作用
摘要
急性肾损伤（acute renal injury，AKI）是危重症患者的常见并发症，肾脏替代治疗（renal replacement therapy，RRT）是AKI时肾脏支持的主要手段。近年来，多种肾损伤特异性生物学标志物的出现，为AKI发生的预测和早期诊断提出了新的手段。2005年，美国肾脏病学会将急性肾损伤的生物学标志物列为最优先研究项目。
出处
《中国血液净化》
2013年第4期216-218,共3页
Chinese Journal of Blood Purification
基金
首都医学发展基金项目(2009-3190)
参考文献24
-
1Berl T. American Society of Nephrology Renal ResearchReport [J]. Am Soc Nephrol , 2005,16:1886-903.
-
2Soni SS, Pophale R, Ronco C. New biomarkers for acuterenal injury [J] . Clin Chem Lab Med, 2011, 49:1257-1263.
-
3Bennett M, Dent CL, Ma Q, et al.Urine NGAL PredictsSeverity of Acute Kidney Injury After Cardiac Surgery: AProspective Study[J]. Clin J Am Soc Nephrol, 2008, 3:665-673.
-
4Cruz DN, de Cal M, Garzotto F, et al. Plasma neutrophilgelatinase-associated lipocalin is an early biomarkerfor acute kidney injury in an adult ICU population [J].Intensive Care Med, 2010, 36:444-451.
-
5Bagshaw SM, Bennett M, Haase M, et al. Plasma and urineneutrophil gelatinase-associated lipocalin in septic ver-sus non-septic acute kidney injury in critical illness[J]. Intensive Care Med, 2010, 36:452-461.
-
6Nickolas TL, 0, Rourke MJ, Yang J, et al. Sensitivityand Specificity of a Single Emergency Department Mea-surement of Urinary Neutrophil Gelatinase? AssociatedLipocalin for Diagnosing Acute Kidney Injury[J]. AnnIntern Med, 2008, 148:810-819.
-
7Constantin JM, Futier E, Perbet S, et al. Plasma neutro-phil gelatinase tbssociated lipocalin is an early markerof acute kidney injury in adult critically ill patients:a prospective study[J]. Crit Care , 2010, 25:176el杆6.
-
8Endre ZH, Pickering JW, ffalker RJ, et al. Improvedperformance of urinary biomarkers of acute kidney injuryin the critically ill by stratification for injury dura-tion and baseline renal function [J]. Kidney Int, 2011,79: 1119 -1130.
-
9lichida K, Gotoh A.Measurement of cystatin C and crea-tinine in urine [J]. Clin Chim Acta, 2002, 323:121-128.
-
10Ferguson MA, Vaidya VS, Bonventre JV. Biomarkers ofnephrotoxic acute kidney injury [J]. Toxicology, 2008,245: 182-193.
-
1叶俏.重症监护治疗学基础知识(四) 肾脏支持[J].英国医学杂志中文版,2000,3(3):128-131.
-
2张文筱,秦秉玉.急性肾损伤患者肾替代治疗时机:宜早宜晚?[J].中华重症医学电子杂志,2017,3(1):69-72. 被引量：1
-
3查艳,张湘燕.肾脏替代治疗时抗生素的应用[J].中华结核和呼吸杂志,2015,38(1):7-10. 被引量：1
-
4王瑞霞,王杨威,董文鹏,苗里宁,孙晶.急性肾损伤的容量评估及管理[J].中国血液净化,2017,16(2):77-79. 被引量：3
-
5金仁琴,张桂香,范廷婷.床旁CRRT治疗护理15例[J].齐齐哈尔医学院学报,2007,28(21):2672-2673.
-
6叶白如,郑育.CRRT治疗重症急性胰腺炎的疗效观察及护理[J].浙江创伤外科,2006,11(6):556-557. 被引量：2
-
7季大玺,吴丛业.肾脏替代治疗在急性肾损伤应用中的争议和共识[J].医学研究生学报,2015,28(9):897-903. 被引量：16
-
8徐激斌,徐志云,邹良建,梅举,王志农,于伟勇,张伟英.13例心脏术后急性严重肾功能衰竭持续肾脏替代疗法的治疗体会[J].第二军医大学学报,2004,25(4):464-464. 被引量：6
-
9俞雨生,程慧栋.自动化腹膜透析在急性肾损伤患者中的合理运用[J].中国血液净化,2017,16(2):80-82. 被引量：4
-
10尤永珂,杨陈,刘华锋.急性肾损伤新型生物标志物[J].中国中西医结合肾病杂志,2010,11(3):268-270. 被引量：12
